LINC-PINT and ovarian cancer: Reduced LINC-PINT expression promoted interaction with BRAF-activated non-coding RNA/mitogen-activated protein kinase, preventing tumour migration, invasion and proliferative growth, sensitised triple-negative breast cancer cells (TNBC) to chemotherapeutics and sponged miR-374a-5p, suppressing the invasiveness of ovarian cancer (He T. et al., 2021).